Highlights bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 11:35:24 2024-05-23 am EDT			5-day change	1st Jan Change
94.7 ^EUR	+0.32%		-1.30%	-5.86%

May. 23	BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	MT
May. 23	BioMérieux: initiative against antibiotic resistance in Malawi	CF

BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	May. 23	MT
BIOMÉRIEUX : Berenberg raises its target	Apr. 26	CF
BIOMÉRIEUX : Stifel raises target price	Apr. 10	CF
BIOMÉRIEUX : Oddo BHF raises its target price	Apr. 10	CF
BIOMÉRIEUX : Invest Securities raises its target	Apr. 10	CF
BIOMERIEUX : A strong start to 2024	Apr. 09
BioMérieux: hailed for its business review and targets	Apr. 09	CF
BioMérieux: targets set for 2024-28	Apr. 09	CF
BioMérieux: growth of over 6% in Q1	Apr. 09	CF
BioMérieux: food safety initiative	Apr. 05	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	Mar. 14
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
BioMérieux: RNPG down 21% in 2023	Mar. 14	CF
BioMérieux Buys Remaining 84% Stake in Canada's Lumed	Jan. 08	MT
BioMérieux: full acquisition of Lumed	Jan. 08	CF
BioMérieux S.A. acquired remaining 84% stake in Luméd inc.	Jan. 04	CI
BIOMÉRIEUX : Invest Securities remains Buy after sales figures	23-10-27	CF
BioMérieux: confirms targets for fiscal 2023	23-10-26	CF
BioMerieux Partners with White Labs to Develop GENE-Up® BrewPRO? Yeast Slurry	23-10-24	CI
Oxford Nanopore gets bioMerieux backing as announces clinical foray	23-10-19	AN

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 10:38 am EDT